MEVIS MEDICAL SOLUTIONS AGMEVIS MEDICAL SOLUTIONS AGMEVIS MEDICAL SOLUTIONS AG

MEVIS MEDICAL SOLUTIONS AG

No trades
See on Supercharts
Market capitalization
‪46.23 M‬EUR
‪4.92 M‬EUR
‪17.34 M‬EUR
‪1.82 M‬
Beta (1Y)
0.20

About MEVIS MEDICAL SOLUTIONS AG

CEO
Marcus Kirchhoff
Website
Headquarters
Bremen
Employees (FY)
114
Founded
1997
ISIN
DE000A0LBFE4
FIGI
BBG000TVDNZ6
MeVis Medical Solutions AG engages in the provision of software for the analysis and processing of image data. It offers its solution to manufacturers of medical devices and medical information technology-platforms. The company was founded in 1997 and is headquartered in Bremen, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of M3V is 25.200 EUR — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange MEVIS MEDICAL SOLUTIONS AG stocks are traded under the ticker M3V.
MEVIS MEDICAL SOLUTIONS AG is going to release the next earnings report on May 27, 2024. Keep track of upcoming events with our Earnings Calendar.
M3V stock is 0.80% volatile and has beta coefficient of 0.20. Check out the list of the most volatile stocks — is MEVIS MEDICAL SOLUTIONS AG there?
Yes, you can track MEVIS MEDICAL SOLUTIONS AG financials in yearly and quarterly reports right on TradingView.
M3V stock has risen by 9.57% compared to the previous week, the month change is a 10.53% rise, over the last year MEVIS MEDICAL SOLUTIONS AG has showed a 23.64% decrease.
M3V net income for the last quarter is ‪3.09 M‬ EUR, while the quarter before that showed ‪1.83 M‬ EUR of net income which accounts for 68.97% change. Track more MEVIS MEDICAL SOLUTIONS AG financial stats to get the full picture.
Today MEVIS MEDICAL SOLUTIONS AG has the market capitalization of ‪46.23 M‬, it has decreased by 3.23% over the last week.
Yes, M3V dividends are paid annually. The last dividend per share was 0.95 EUR. As of today, Dividend Yield (TTM)% is 3.74%. Tracking MEVIS MEDICAL SOLUTIONS AG dividends might help you take more informed decisions.
MEVIS MEDICAL SOLUTIONS AG dividend yield was 3.35% in 2023, and payout ratio reached 35.15%. The year before the numbers were 2.78% and 22.20% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, M3V shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEVIS MEDICAL SOLUTIONS AG stock right from TradingView charts — choose your broker and connect to your account.
M3V reached its all-time high on Nov 16, 2007 with the price of 55.000 EUR, and its all-time low was 2.510 EUR and was reached on Nov 10, 2011.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 114.00 employees. See our rating of the largest employees — is MEVIS MEDICAL SOLUTIONS AG on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEVIS MEDICAL SOLUTIONS AG technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEVIS MEDICAL SOLUTIONS AG stock shows the sell signal. See more of MEVIS MEDICAL SOLUTIONS AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEVIS MEDICAL SOLUTIONS AG EBITDA is ‪4.56 M‬ EUR, and current EBITDA margin is 28.12%. See more stats in MEVIS MEDICAL SOLUTIONS AG financial statements.